Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cassella Farbwerke Mainkur was a significant German chemical and pharmaceutical manufacturer headquartered in Frankfurt-Fechenheim. Founded in 1870, the company initially specialized in synthetic dyes before expanding into pharmaceuticals, where it developed notable cardiovascular drugs such as the coronary vasodilator Intensain (chromonar). Historically, Cassella was a constituent of the I.G. Farben trust and was later acquired by Hoechst AG in 1970. The company played a crucial role in the development of synthetic chemistry in Germany during the 19th and 20th centuries. Today, its operations and legacy are integrated into Sanofi following a series of industry mergers, while its former production site continues to operate as an industrial park for chemical manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cassella Farbwerke Mainkur.